T0	KEYPHRASE-NOTYPES 0 9	Arthritis
T1	KEYPHRASE-NOTYPES 15 33	late manifestation
T2	KEYPHRASE-NOTYPES 37 49	Lyme disease
T3	KEYPHRASE-NOTYPES 69 75	months
T4	KEYPHRASE-NOTYPES 86 95	tick bite
T5	KEYPHRASE-NOTYPES 108 115	history
T6	KEYPHRASE-NOTYPES 119 135	erythema migrans
T7	KEYPHRASE-NOTYPES 139 148	tick bite
T8	KEYPHRASE-NOTYPES 165 173	Patients
T9	KEYPHRASE-NOTYPES 195 213	persistent attacks
T10	KEYPHRASE-NOTYPES 217 231	joint swelling
T11	KEYPHRASE-NOTYPES 236 240	pain
T12	KEYPHRASE-NOTYPES 264 280	large joints
T13	KEYPHRASE-NOTYPES 292 296	knee
T14	KEYPHRASE-NOTYPES 307 313	period
T15	KEYPHRASE-NOTYPES 317 323	months
T16	KEYPHRASE-NOTYPES 327 340	several years
T17	KEYPHRASE-NOTYPES 347 374	systemic manifestations
T18	KEYPHRASE-NOTYPES 380 389	diagnosis
T19	KEYPHRASE-NOTYPES 439 440	B
T20	KEYPHRASE-NOTYPES 442 453	burgdorferi
T21	KEYPHRASE-NOTYPES 457 462	ELISA
T22	KEYPHRASE-NOTYPES 467 487	IgG Western blotting
T23	KEYPHRASE-NOTYPES 511 527	strong responses
T24	KEYPHRASE-NOTYPES 531 556	many spirochetal proteins
T25	KEYPHRASE-NOTYPES 562 572	many bands
T26	KEYPHRASE-NOTYPES 582 593	PCR testing
T27	KEYPHRASE-NOTYPES 597 611	synovial fluid
T28	KEYPHRASE-NOTYPES 616 617	B
T29	KEYPHRASE-NOTYPES 619 634	burgdorferi DNA
T30	KEYPHRASE-NOTYPES 662 680	antibiotic therapy
T31	KEYPHRASE-NOTYPES 690 694	test
T32	KEYPHRASE-NOTYPES 704 722	reliable indicator
T33	KEYPHRASE-NOTYPES 726 749	spirochetal eradication
T34	KEYPHRASE-NOTYPES 760 780	antibiotic treatment
T35	KEYPHRASE-NOTYPES 788 803	spirochetal DNA
T36	KEYPHRASE-NOTYPES 822 841	spirochetal killing
T37	KEYPHRASE-NOTYPES 843 850	Initial
T38	KEYPHRASE-NOTYPES 863 872	therapies
T39	KEYPHRASE-NOTYPES 883 896	30-day course
T40	KEYPHRASE-NOTYPES 900 916	oral doxycycline
T41	KEYPHRASE-NOTYPES 920 931	amoxicillin
T42	KEYPHRASE-NOTYPES 946 954	patients
T43	KEYPHRASE-NOTYPES 960 976	persistent joint
T44	KEYPHRASE-NOTYPES 994 1006	oral therapy
T45	KEYPHRASE-NOTYPES 1008 1022	IV ceftriaxone
T46	KEYPHRASE-NOTYPES 1034 1039	weeks
T47	KEYPHRASE-NOTYPES 1058 1078	successful treatment
T48	KEYPHRASE-NOTYPES 1082 1098	small percentage
T49	KEYPHRASE-NOTYPES 1102 1110	patients
T50	KEYPHRASE-NOTYPES 1120 1140	persistent arthritis
T51	KEYPHRASE-NOTYPES 1145 1151	months
T52	KEYPHRASE-NOTYPES 1155 1168	several years
T53	KEYPHRASE-NOTYPES 1189 1210	IV antibiotic therapy
T54	KEYPHRASE-NOTYPES 1251 1275	anti-inflammatory agents
T55	KEYPHRASE-NOTYPES 1277 1283	DMARDs
T56	KEYPHRASE-NOTYPES 1288 1299	synovectomy
T57	KEYPHRASE-NOTYPES 1305 1322	antibody response
T58	KEYPHRASE-NOTYPES 1326 1327	B
T59	KEYPHRASE-NOTYPES 1329 1340	burgdorferi
T60	KEYPHRASE-NOTYPES 1363 1372	treatment
T61	KEYPHRASE-NOTYPES 1382 1386	test
T62	KEYPHRASE-NOTYPES 1418 1423	years
T63	KEYPHRASE-NOTYPES 1430 1437	therapy
